COVID-19 and Depression.

Shader, Richard I

Shader, Richard I.

Shader RI; Tufts University School of Medicine, Boston, MA, United States. Electronic address: Richard.Shader@tufts.edu.

Clin Ther ; 42(6): 962-963, 2020 06.

Article in English | MEDLINE | ID: covidwho-831286

ABSTRACT

ABSTRACT

The COVID-19 pandemic embodies overwhelming stresses-unemployment, death, and isolation, among others. When called upon, clinicians must try to sort out demoralization from depression. This commentary discerns the characteristics of demoralization versus depression, and suggests solutions for both, together with a cautionary word on the use chloroquine and hydroxychloroquine in patients with COVID-19.

Subject(s)

Betacoronavirus/pathogenicity; Coronavirus Infections/epidemiology; Coronavirus Infections/psychology; Depression/diagnosis; Pandemics; Pneumonia, Viral/epidemiology; Pneumonia, Viral/psychology; Anxiety/diagnosis; Anxiety/psychology; COVID-19; Chloroquine/therapeutic use; Coronavirus Infections/drug therapy; Depression/psychology; Humans; Hydroxychloroquine/therapeutic use; Pneumonia, Viral/drug therapy; SARS-CoV-2; Unemployment/psychology

Keywords

COVID-19; Chloroquine; Demoralization; Depression; Hydroxychloroquine

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Depression / Pandemics / Betacoronavirus Type of study: Diagnostic study / Observational study / Qualitative research Limits: Humans Language: English Journal: Clin Ther Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google